EMEA-000555-PIP01-09-M06

Key facts

Invented name
Dacogen
Active substance
Decitabine
Therapeutic area
Oncology
Decision number
P/0234/2017
PIP number
EMEA-000555-PIP01-09-M06
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
Treatment of acute myeloid leukaemia
Route(s) of administration
Intravenous use
Contact for public enquiries
Janssen-Cilag International NV
Ireland
Tel. +353 857446696
E-mail: nbuhl@its.jnj.com

 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating